Form 4: Immix Biopharma CEO Ilya Rachman Acquires Additional Shares
SEC Form 4 Filing
Ilya Rachman, CEO and Chairman of Immix Biopharma, Inc., purchased 3,300 shares of common stock at $1.8091 per share on June 4, 2024.
Summary
- On June 4, 2024, Ilya Rachman, the CEO and Chairman of Immix Biopharma, Inc., acquired 3,300 shares of the company's common stock.
- The purchase price was $1.8091 per share.
- Following the transaction, Rachman directly owns 1,133,659 shares of Immix Biopharma's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally seen as a good sign, but the impact is limited as it's a relatively small transaction.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of the transaction: Ilya Rachman purchased 3,300 shares of Immix Biopharma stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.